跳至主要内容
临床试验/JPRN-UMIN000019264
JPRN-UMIN000019264已完成未知

Effect of daily ingestion of yogurt drink containing Lactobacillus gasseri SBT2055 on antibody response to influenza vaccine in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel group comparison study. - Effect of daily ingestion of Lactobacillus gasseri SBT2055 on antibody response to influenza vaccine.

Hokkaido Information University0 个研究点目标入组 160 人开始时间: 2015年10月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal, endocrine or metabolic disorders or affected with an infectious disease which is required to report to the authorities. 2.Subjects who are suspected to have acute infection such as influenza, etc. 3.Subjects who are under treatment for chronic inflammatory diseases, autoimmune diseases or allergies, etc. 4.Subjects who were vaccinated within 12 weeks prior to participating this study. 5.Subjects who have had anaphylactic reaction, etc. to influenza vaccine in the past. 6.Subjects who have a major surgical history such as gastrectomy, gastrorrhaphy, enterectomy or other serious gastrointestinal surgeries. 7.Pre- or post-menopausal women having complaints of obvious physical changes. 8.Subjects with unusually high or low blood pressure, or with abnormal hematological data. 9.Subjects with serious anemia. 10.Subjects with a history of allergy to medicine or food (especially dairy products, eggs or chicken meat). 11.Subjects who regularly take drugs which may affect the immune function Chinese herbal medicine, health food or supplements (mushrooms, seaweed, nucleic acids, yeast, lactobacillus, etc.) 12.Subjects who regularly take drugs for constipation or diarrhea. 13.Subjects who regularly take the products such as "Megumi Yogurt" "Megumi Drink Type" "Megumi 0 Fat" or other yogurt products from Megumi series of MEGMILK SNOW BRAND Co., Ltd. 14.Heavy smokers, alcohol addicts or subjects with irregular lifestyle. 15.Subjects who donate either 400ml whole blood within 12 weeks or 200ml whole blood within 4 weeks or blood component within 2 weeks prior to this study. 16.Subjects who are pregnant or expected to be pregnant, or lactating during the study. 17.Subjects who participate in other clinical trials within the last one month prior to this study. 18.Any other medical reasons judged by the principal investigator.

研究者

相似试验